Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway—PaVDaG study)

Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program

(2015) M. Arbyn et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

(2015) M. Arbyn et al.   CLINICAL MICROBIOLOGY AND INFECTION

Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials

(2015) F. Verdoodt et al.   EUROPEAN JOURNAL OF CANCER

Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework

(2015) K. Cuschieri et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment

(2015) Grazyna A Stanczuk et al.   JOURNAL OF CLINICAL PATHOLOGY

Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program

(2014) Laurie W Smith et al.   BMC PUBLIC HEALTH

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

(2014) Marc Arbyn et al.   LANCET ONCOLOGY

Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis

(2014) N. Pathak et al.   BMJ-British Medical Journal

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

The Interplay of Age Stratification and HPV Testing on the Predictive Value of ASC-US Cytology

(2012) Mark H. Stoler et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

High-risk HPV testing on self-sampledversusclinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening

(2012) Peter J.F. Snijders et al.   INTERNATIONAL JOURNAL OF CANCER

The Correlation Between Human Papillomavirus Positivity and Abnormal Cervical Cytology Result Differs by Age Among Perimenopausal Women

(2012) Anne F. Rositch et al.   Journal of Lower Genital Tract Disease

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Detection of human papillomavirus DNA in urine. A review of the literature

(2011) A. Vorsters et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing

(2011) Jerome L. Belinson et al.   INTERNATIONAL JOURNAL OF CANCER

How to evaluate emerging technologies in cervical cancer screening?

(2009) Marc Arbyn et al.   INTERNATIONAL JOURNAL OF CANCER

OP5-5 Evaluation of a new strategy for cervix cancer screening in women who do not access to pap smear screening in West Brittany, using a urine test for human papillomavirus (HPV) detection on a large scale plateform combining EasyMag extractor and real-time PCR LightCycler system (the PAPU29 PHASE 1 study)

(2009) C. Payan et al.   JOURNAL OF CLINICAL VIROLOGY

Validation of high-risk HPV tests for primary cervical screening

(2009) C.J.L.M. Meijer et al.   JOURNAL OF CLINICAL VIROLOGY

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER